MariMed Commences Adult-Use Sales at Thrive Wellness Dispensary in Tiffin, Ohio

NORWOOD, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced it has commenced adult-use retail sales at its Thrive Wellness dispensary in Tiffin, Ohio. Since its opening in June 2023, the dispensary has been operating as a […]

Electra Achieves Technical Grade Lithium Carbonate in Recycling Program

TORONTO, Sept. 24, 2024 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company“) is pleased to announce the successful achievement of greater than 99% purity, or technical grade, lithium carbonate product. These results further bolster the Company’s ability to produce high-quality, technical and battery-grade products from its black mass

VR Resources Expands Empire Property and Reports Copper – Gold – PGE Mineralization

VANCOUVER, British Columbia, Sept. 24, 2024 (GLOBE NEWSWIRE) — VR Resources Ltd. (TSX.V: VRR, FSE: 5VR; OTCBB: VRRCF), the “Company“, or “VR“, is pleased to report results of work done to date on the expanded Empire property in northern Ontario and lays out plans for 3D DCIP survey on the Wildwood target. The Empire property

Midland and Wallbridge Commence Drilling on the Casault Property

MONTREAL, Sept. 24, 2024 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland“) (TSX-V: MD), in partnership with Wallbridge Mining Company Ltd (“Wallbridge“), is pleased to announce the commencement of a diamond drilling campaign in the eastern part of the Casault gold property. Highlights: Five (5) holes, 1,100m drilling program underway; Regional and structural mapping conducted in

HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset

NEW YORK and VIENNA, Sept. 24, 2024 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ: HOOK) (“HOOKIPA” or the “Company”), a clinical-stage biopharmaceutical company developing next generation immunotherapeutics for the treatment of cancer and serious infectious diseases, today announced that the Company will present preclinical data related to the HB-700 program for the treatment of KRAS

Repligen Opens Training & Innovation Center to Elevate Customer Experience

WALTHAM, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the grand opening of its Repligen Training & Innovation Center (“RTIC”) at its Waltham headquarters. The opening celebration, held on the evening of September 23, attracted a group of over 150 biopharma and

BankNewport Reports Deposit Account Opening Process Accelerated by as much as Ninety Percent, Streamlining a Key Consumer Banking Experience with nCino

WILMINGTON, N.C., Sept. 24, 2024 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced that BankNewport is live on the nCino Platform. Since selecting nCino as a foundational technology partner, the Rhode Island-based community bank has implemented multiple nCino solutions, including Commercial Lending, Marine Lending, Business and

Ocugen to Participate in a Fireside Chat at Chardan’s 8th Annual Genetic Medicines Conference

MALVERN, Pa., Sept. 24, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that Dr. Arun Upadhyay, Chief Scientific Officer, Head of Research & Development, will participate in an in-person fireside chat moderated by

Atsena Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines Conference

DURHAM, N.C., Sept. 24, 2024 (GLOBE NEWSWIRE) — Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, today announced that it will present at Chardan’s 8th Annual Genetic Medicines Conference taking place September 30 – October 1, 2024, in New York City. Chief

AGF Partners with Archer to Support Rapid Growth of SMA Model Business

TORONTO , Sept. 24, 2024 (GLOBE NEWSWIRE) — AGF Management Limited (TSX: AGF.B), is pleased to announce a partnership with Archer Holdco, LLC (“Archer”) to help further grow its Separately Managed Accounts (SMA) model business. AGF will leverage the technology capabilities and infrastructure of Archer, a leading technology-enabled service provider to the investment management industry.

Scroll to Top